Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lavi

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Clinical Immunology (Orlando, Fla.)|January 6, 2001
Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectivelyC S Constantinescu, B Hilliard, E Ventura, et al.
Radiology|February 1, 1992
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imagingV Dousset, R I Grossman, K N Ramer, et al.
The American Journal of Pathology|November 5, 1997
CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neuronsE Lavi, J M Strizki, A M Ulrich, et al.
Neuropathology and Applied Neurobiology|July 5, 2001
CXCR3 expression in human central nervous system diseasesS H Goldberg, P van der Meer, J Hesselgesser, et al.
Blood|June 15, 1997
Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cellsA A Higazi, E Lavi, K Bdeir, et al.
Cancer Research|April 1, 1985
Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusionS Zimm, L J Ettinger, J S Holcenberg, et al.
Journal of Virology|April 1, 1997
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutationS Rana, G Besson, D G Cook, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Clinical Immunology (Orlando, Fla.)|January 6, 2001
Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectivelyC S Constantinescu, B Hilliard, E Ventura, et al.
Radiology|February 1, 1992
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imagingV Dousset, R I Grossman, K N Ramer, et al.
The American Journal of Pathology|November 5, 1997
CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neuronsE Lavi, J M Strizki, A M Ulrich, et al.
Neuropathology and Applied Neurobiology|July 5, 2001
CXCR3 expression in human central nervous system diseasesS H Goldberg, P van der Meer, J Hesselgesser, et al.
Blood|June 15, 1997
Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cellsA A Higazi, E Lavi, K Bdeir, et al.
Cancer Research|April 1, 1985
Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusionS Zimm, L J Ettinger, J S Holcenberg, et al.
Journal of Virology|April 1, 1997
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutationS Rana, G Besson, D G Cook, et al.
Pageof 12